Exclusion of the nuclear factor-≃B3 (REL A) gene as candidate for the multiple endocrine neoplasia type 1 (MEN 1) gene

Biochemical and Molecular Medicine

Volumn 60, Issue 1, 1997, Pages 76-79

  Landsvater, Rudy M ^a   De Wit, Mireille J ^a   Peterson, Luke F ^a   Sinke, Richard J ^b   Geurts Van Kessel, Ad ^b   Lips, Cornelis J M ^a   Höppener, Jo W M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ARTICLE; CANCER GENETICS; CONTROLLED STUDY; DNA DETERMINATION; DNA SEQUENCE; GENETIC ANALYSIS; HUMAN; MULTIPLE ENDOCRINE NEOPLASIA; SOUTHERN BLOTTING;

EID: 0031080614     PISSN: 10773150     EISSN: None     Source Type: Journal    
DOI: 10.1006/bmme.1996.2561     Document Type: Article

References (16)

1. 1. Larsson C, Nordenskjöld M. Multiple endocrine neoplasia. Cancer Surv 9:703-723, 1990.
2. 2. Larsson C, Skogseid B, Oberg K, Nakamura Y, Nordenskjöld M. Multiple endocrine neoplasia type l gene maps to chromosome 11 and is lost in insulinoma. Nature 332:85-87, 1988.
3. 3. Weber G, Friedman E, Grimmond S, Hayward NK, Phelan C, Skogseid B, Gobi A, Zedenius I, Sandelin K. The phospholipase C β3 gene located in the MEN 1 region shows loss of expression in endocrine tumors. Hum Mol Genet 3:1775-1781, 1995.
4. 4. Larsson C, Weber G, Kvanta E, Lewis K, Janson M, Jones C, Glaser T, Evans G, Nordenskjöld M. Isolation and mapping of polymorphic cosmid clones used for sublocalization of the multiple endocrine neoplasia type 1 (MEN1) locus. Hum Genet 89:187-193, 1992.
5. 5. Thanos D, Maniatis T. NF-κB: A lesson in family values. Cell 80:529-532, 1995.
6. 6. Ballard DW, Walker WH, Doerre S, Sista P, Molitor JA, Dixon EP, Peffer NJ, Hannink M, Greene WC. The v-rel oncogene encodes a κB enhancer binding protein that inhibits NF-κB function. Cell 63:803-814, 1990.
7. 7. Deloukas P, Dauwerse JG, Van Ommen GJB, Van Loon APGM. The human NFKB3 gene encoding the p65 subunit of transcription factor NF-κB is located on chromosome 11q12. Genomics 19:592-594, 1994.
8. 8. Van Heyningen V, Little PFR. Report of the fourth international workshop on human chromosome 11 mapping 1994. Cytogenet Cell Genet 69:128-158, 1995.
9. 9. Shows TB, Alders M, Bennett S, Burbee D, Cartwright P, Chandrasekharappa S, Cooper P, Courseaux A, Davies C, Devignes MD, Devilee P, Elliott R, Evans G, Fantes J, Garner H, Gaudray P, Gerhard DS, Gessler M, Higgins M, Hummerich H, James M, Lagercrantz J, Litt M, Little P, Mannens M, Munroe D, Nowak N, O'Brien S, Parker N, Perlin M, Reid L, Richard C, Sawicki M, Swallow D, Thakker R, Van Heyningen V, Van Schothorst E, Vorechovsky I, Wadelius C, Weber B, Zabel B. Report of the fifth international workshop on human chromosome 11 mapping 1996. Cytogenet Cell Genet 74:1-56, 1996.
10. 10. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:3, 1988.
11. 11. Sinke RJ. Molecular Characterization of Chromosomal Aberrations in Human Germ Cell Tumors. Thesis, University of Nijmegen, The Netherlands, 1996.
12. 12. De Wit MJ, Landsvater RM, Sinke RJ, Geurts van Kessel A, Lips CJM, Höppener JWM. Exclusion of the phosphatidylinositol-specific phospholipase C β3 (PLC β3) gene as candidate for the multiple endocrine neoplasia type 1 (MEN 1) gene. Hum Genet 99:133-137, 1997.
13. 13. Landsvater RM, Jansen RPM, Hofstra RMW, Buys CHCM, Lips CJM, Ploos van Amstel HK. Mutation analysis of the Ret proto-oncogene in Dutch families with MEN 2A, MEN 2B and FMTC: Two novel mutations and one de novo mutation for MEN 2A. Hum Genet 97:11-14, 1996.
14. 14. Knudson AG. Hereditary cancer, oncogenes and anti-oncogenes. Cancer Res. 45:1437-1443, 1985.
15. 15. Deloukas P, van Loon APGM. Genomic organization of the gene encoding the p65 subunit of NF-κB: Multiple variants of the p65 protein may be generated by alternative splicing. Hum Mol Genet 2:1895-1900, 1993.
16. 16. Chen F, Kishida T, Yao M, Hustad T, Glavec D, Dean M, Gnarra JR, Orcutt ML, Duh FM, Glenn G, Green J, Hsia YE, Lamiell J, Li H, Wei MH, Schmidt L, Tory K, Kuzmin I, Stackhouse T, Latif F, Linehan WM, Lerman M, Zbar B. Germline mutations in the Von Hippel-Lindau disease tumor suppressor gene: Correlations with phenotype. Hum Mutat 5:66-75, 1995.